- Home
- Companies
- IntraOp Medical, Inc.
- Applications
- Intraoperative Radiation Therapy (IORT) ...
Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI - Medical / Health Care - Clinical Services
You likely already know that electron-beam IORT has been successfully treating multiple cancer indications for nearly 50 years and has been treating breast cancer since the early 1990’s. The first accelerated partial breast irradiation (APBI) treatment with the IntraOp® Mobetron® was performed in 2006. Today, more than 20,000 women have been treated with electron IORT demonstrating equivalency in local control with reduced toxicity and improved cosmesis. More than 10,000 breast cancer patients have been treated with the Mobetron.
The American Society of Radiation Oncology (ASTRO) issued an updated Consensus Statement on Accelerated Partial Breast Irradiation (APBI) in the journal Practical Radiation Oncology confirming the use of electron-beam IORT as an effective modality for the treatment of suitable patients with invasive breast cancer.
Furthermore, the Consensus removes experimental status and recognizes the single fraction electron-beam IORT modality, validating Mobetron and distinguishing it from all other IORT treatment options available in the fight against cancer.
The milestone distinguishes the Mobetron from all other IORT treatment options and further validates that as few as two (2) minutes of precision targeted electron beam treatment with the Mobetron can replace six weeks of conventional, post-operative external beam x-ray radiation of the entire breast. For qualified patients with breast cancer this means faster treatment, faster recovery and significantly fewer side effects, as non-involved tissue is spared.
Citing the current status of the TARGIT trial, the ASTRO Consensus Statement recommended that “low-energy x-ray IORT should continue to be used within the context of a prospective registry or clinical trial to ensure long-term local control and toxicity outcomes are prospectively monitored.”